Literature DB >> 15770718

Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy.

Hsien-Chung Yu1, Jin-Shiung Cheng, Kwok-Hung Lai, Chi-Pin Lin, Gin-Ho Lo, Chiun-Ku Lin, Ping-I Hsu, Hoi-Hung Chan, Ching-Chu Lo, Wei-Lun Tsai, Wen-Chi Chen.   

Abstract

AIM: To evaluate the factors affecting the early tumor recurrence within one year in cirrhotic patients having a single small hepatocellular carcinoma (HCC) after complete tumor necrosis by radiofrequency ablation (RFA) therapy.
METHODS: Thirty patients with a single small HCC received RFA therapy by a RFA 2000 generator with LeVeen needle. Tri-phase computerized tomogram was followed every 2 to 3 mo after RFA. The clinical effects and tumor recurrence were recorded.
RESULTS: The initial complete tumor necrosis rate was 86.7%. Twenty-two patients were followed for more than one year. The local and overall recurrence rates were 13.6% and 36.4%, 33.3% and 56.2%, 46.6% and 56.2% at 12, 24 and 30 mo, respectively. No major complication or procedure-related mortality was found. The risk factors for early local tumor recurrence within one year were larger tumor size, poor pathologic differentiation of tumor cells and advanced tumor staging. The age of patients with new tumor formation within one year was relatively younger (55.1+/-8.3 vs 66.7+/-10.8, P = 0.029).
CONCLUSION: Large tumor size, poor pathologic differentiation of tumor cells and advanced tumor staging are the risk factors for early local tumor recurrence within one year, and young age is the positive predictor for new tumor formation within one year.

Entities:  

Mesh:

Year:  2005        PMID: 15770718      PMCID: PMC4305684          DOI: 10.3748/wjg.v11.i10.1439

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

4.  Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.

Authors:  S Roayaie; M B Haim; S Emre; T M Fishbein; P A Sheiner; C M Miller; M E Schwartz
Journal:  Ann Surg Oncol       Date:  2000-12       Impact factor: 5.344

5.  Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.

Authors:  Yasuji Komorizono; Makoto Oketani; Katsumi Sako; Naruhiro Yamasaki; Toshihiko Shibatou; Masahiko Maeda; Kazunori Kohara; Shuhou Shigenobu; Kazuaki Ishibashi; Terukatsu Arima
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

Review 6.  Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies.

Authors:  Courtney L Scaife; Steven A Curley
Journal:  Surg Oncol Clin N Am       Date:  2003-01       Impact factor: 3.495

7.  Hepatic resection for hepatocellular carcinoma. An audit of 343 patients.

Authors:  E C Lai; S T Fan; C M Lo; K M Chu; C L Liu; J Wong
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

8.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

Authors:  Riccardo A Lencioni; Hans-Peter Allgaier; Dania Cioni; Manfred Olschewski; Peter Deibert; Laura Crocetti; Holger Frings; Joerg Laubenberger; Ina Zuber; Hubert E Blum; Carlo Bartolozzi
Journal:  Radiology       Date:  2003-05-20       Impact factor: 11.105

9.  Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Lawrence E Harrison; Baburao Koneru; Phil Baramipour; Adrian Fisher; Alison Barone; Dorian Wilson; Andrew Dela Torre; Kyunghee C Cho; Daniel Contractor; Maria Korogodsky
Journal:  J Am Coll Surg       Date:  2003-11       Impact factor: 6.113

10.  Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process.

Authors:  Min-Hua Chen; Wei Yang; Kun Yan; Ming-Wu Zou; Luigi Solbiati; Ji-Bin Liu; Ying Dai
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

View more
  18 in total

Review 1.  Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future.

Authors:  Bradford J Wood; Julia K Locklin; Anand Viswanathan; Jochen Kruecker; Dieter Haemmerich; Juan Cebral; Ariela Sofer; Ruida Cheng; Evan McCreedy; Kevin Cleary; Matthew J McAuliffe; Neil Glossop; Jeff Yanof
Journal:  J Vasc Interv Radiol       Date:  2007-01       Impact factor: 3.464

2.  Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors.

Authors:  Brent D Weinberg; Ravi B Patel; Agata A Exner; Gerald M Saidel; Jinming Gao
Journal:  J Control Release       Date:  2007-08-25       Impact factor: 9.776

Review 3.  Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.

Authors:  Yasunori Minami; Naoshi Nishida; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 4.  The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation.

Authors:  Eric D McLoney; Ari J Isaacson; Patrick Keating
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

5.  Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization.

Authors:  Akitoshi Douhara; Tadashi Namisaki; Kei Moriya; Mitsuteru Kitade; Kosuke Kaji; Hideto Kawaratani; Kosuke Takeda; Yasushi Okura; Hiroaki Takaya; Ryuichi Noguchi; Norihisa Nishimura; Kenichiro Seki; Shinya Sato; Yasuhiko Sawada; Junichi Yamao; Akira Mitoro; Masakazu Uejima; Tsuyoshi Mashitani; Naotaka Shimozato; Soichiro Saikawa; Keisuke Nakanishi; Masanori Furukawa; Takuya Kubo; Hitoshi Yoshiji
Journal:  Oncol Lett       Date:  2017-06-28       Impact factor: 2.967

6.  A Clinical Scoring System for Predicting Microvascular Invasion in Patients with Hepatocellular Carcinoma Within the Milan Criteria.

Authors:  Tomoki Ryu; Yuko Takami; Yoshiyuki Wada; Masaki Tateishi; Takanobu Hara; Munehiro Yoshitomi; Seiya Momosaki; Kotaro Yasumori; Hideki Saitsu; Koji Okuda
Journal:  J Gastrointest Surg       Date:  2019-02-20       Impact factor: 3.452

7.  Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression.

Authors:  Chang-Hsien Liu; Ronald S Arellano; Raul N Uppot; Anthony E Samir; Debra A Gervais; Peter R Mueller
Journal:  Eur Radiol       Date:  2009-09-16       Impact factor: 5.315

8.  Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation.

Authors:  Kosaku Moribata; Hideyuki Tamai; Naoki Shingaki; Yoshiyuki Mori; Tatsuya Shiraki; Shotaro Enomoto; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Masao Ichinose
Journal:  World J Hepatol       Date:  2012-12-27

9.  Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma < or =4 cm.

Authors:  Toshifumi Wakai; Yoshio Shirai; Takeshi Suda; Naoyuki Yokoyama; Jun Sakata; Pauldion V Cruz; Hirokazu Kawai; Yasunobu Matsuda; Masashi Watanabe; Yutaka Aoyagi; Katsuyoshi Hatakeyama
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

10.  Pre-treatment double- or triple-positive tumor markers are predictive of a poor outcome for patients undergoing radiofrequency ablation for hepatocellular carcinoma.

Authors:  Hidetoshi Nitta; Shigeki Nakagawa; Takayoshi Kaida; Kota Arima; Takaaki Higashi; Katsunobu Taki; Hirohisa Okabe; Hiromitsu Hayashi; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Toru Beppu; Hideo Baba
Journal:  Surg Today       Date:  2016-08-22       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.